Mar 21 |
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet
|
Mar 20 |
Annovis to release efficacy data on Alzheimer's drug in April
|
Mar 20 |
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
|
Mar 18 |
Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock?
|
Mar 6 |
Sell Signal: 3 Stocks to Unload Before the Bubble Bursts
|
Feb 28 |
Annovis Bio falls after Brookline Capital downgrades on PD trial complications
|
Feb 27 |
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
|
Feb 26 |
12 $10 Stocks That Will Triple
|
Feb 14 |
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
|
Feb 12 |
Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects
|